12/1
08:41 am
dgx
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]
Low
Report
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]
12/1
08:30 am
dgx
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States
Low
Report
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States
11/26
09:51 am
dgx
Function Health's $2.5 Billion Bet And Are Blood Testing Startups Sustainable [Forbes]
Low
Report
Function Health's $2.5 Billion Bet And Are Blood Testing Startups Sustainable [Forbes]
11/21
07:04 pm
dgx
Quest Diagnostics (DGX): A Fresh Look at Valuation After Strong Q3 Earnings and Raised Outlook [Yahoo! Finance]
Low
Report
Quest Diagnostics (DGX): A Fresh Look at Valuation After Strong Q3 Earnings and Raised Outlook [Yahoo! Finance]
11/16
09:36 pm
dgx
How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates [Yahoo! Finance]
Low
Report
How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates [Yahoo! Finance]
11/11
04:25 pm
dgx
Quest Diagnostics declares $0.80 dividend [Seeking Alpha]
Low
Report
Quest Diagnostics declares $0.80 dividend [Seeking Alpha]
11/11
04:22 pm
dgx
Quest Diagnostics Declares Quarterly Cash Dividend
Low
Report
Quest Diagnostics Declares Quarterly Cash Dividend
11/3
04:09 pm
dgx
Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference
Low
Report
Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference
10/27
08:17 am
dgx
Quest Diagnostics (NYSE:DGX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Quest Diagnostics (NYSE:DGX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
10/27
07:45 am
dgx
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
Low
Report
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
10/22
10:58 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $195.00 price target on by analysts at Barclays PLC.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $195.00 price target on by analysts at Barclays PLC.
10/22
10:01 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $207.00 price target on by analysts at Morgan Stanley.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $207.00 price target on by analysts at Morgan Stanley.
10/22
10:01 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $205.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $205.00 price target on by analysts at Truist Financial Corporation.
10/21
04:05 pm
dgx
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Low
Report
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
10/21
03:58 pm
dgx
Quest Diagnostics (NYSE:DGX) was given a new $210.00 price target on by analysts at Leerink Partners.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $210.00 price target on by analysts at Leerink Partners.
10/21
03:06 pm
dgx
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
10/21
11:40 am
dgx
Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise [Yahoo! Finance]
Low
Report
Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise [Yahoo! Finance]
10/21
10:35 am
dgx
Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic [Yahoo! Finance]
Low
Report
Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic [Yahoo! Finance]
10/21
06:45 am
dgx
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
Medium
Report
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
10/18
08:33 am
dgx
Looking at the Narrative for Quest Diagnostics as Growth Outlook and Analyst Views Evolve [Yahoo! Finance]
Low
Report
Looking at the Narrative for Quest Diagnostics as Growth Outlook and Analyst Views Evolve [Yahoo! Finance]
10/17
10:03 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $190.00 price target on by analysts at UBS Group AG.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $190.00 price target on by analysts at UBS Group AG.
10/17
08:12 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $210.00 price target on by analysts at Mizuho.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $210.00 price target on by analysts at Mizuho.
10/17
02:53 am
dgx
MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
Low
Report
MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
10/16
11:20 am
dgx
2025-30 Menstrual Cups Market Growth Driven by Gen-Z as Industry Value is Set to Surpass USD 1.2B by 2030, Reports Mordor Intelligence [Yahoo! Finance]
Low
Report
2025-30 Menstrual Cups Market Growth Driven by Gen-Z as Industry Value is Set to Surpass USD 1.2B by 2030, Reports Mordor Intelligence [Yahoo! Finance]
10/14
10:58 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $195.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $195.00 price target on by analysts at Truist Financial Corporation.